BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Diagnosis
9 results:

  • 1. Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies.
    Mogal MR; Jame JA; Sohel M; Mozibullah M; Mahmod MR; Junayed A; Kar N; Arbia L; Al Mamun A; Sikder MA
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2059. PubMed ID: 38639039
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation.
    Javanshir HT; Malekraeisi MA; Ebrahimi SSS; Bereimipour A; Kashani SF; Bostaki AA; Mahmoodzadeh H; Nayernia K
    J Med Life; 2022 Sep; 15(9):1143-1157. PubMed ID: 36415513
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in
    Philpott S; Raikou M; Manchanda R; Lockley M; Singh N; Scott M; Evans DG; Adlard J; Ahmed M; Edmondson R; Woodward ER; Lamnisos A; Balega J; Brady AF; Sharma A; Izatt L; Kulkarni A; Tripathi V; Solomons JS; Hayes K; Hanson H; Snape K; Side L; Skates S; McGuire A; Rosenthal AN
    J Med Genet; 2023 May; 60(5):440-449. PubMed ID: 36319079
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of key genes associated with papillary thyroid microcarcinoma characteristics by integrating transcriptome sequencing and weighted gene co-expression network analysis.
    Yang F; Lian M; Ma H; Feng L; Shen X; Chen J; Fang J
    Gene; 2022 Feb; 811():146086. PubMed ID: 34856364
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel diagnostic nomogram based on serological and ultrasound findings for preoperative prediction of malignancy in patients with ovarian masses.
    Guo Y; Jiang T; Ouyang L; Li X; He W; Zhang Z; Shen H; You Z; Yang G; Lai H
    Gynecol Oncol; 2021 Mar; 160(3):704-712. PubMed ID: 33357959
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
    Xia F; Jiang B; Chen Y; Du X; Peng Y; Wang W; Wang Z; Li X
    Medicine (Baltimore); 2018 Dec; 97(51):e13802. PubMed ID: 30572540
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
    Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Unemployment Risk and Decreased Income Two and Four Years After Thyroid cancer diagnosis: A Population-Based Study.
    Ratzon NZ; Uziely B; de Boer AG; Rottenberg Y
    Thyroid; 2016 Sep; 26(9):1251-8. PubMed ID: 27400754
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.